Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report

Disseminated Intravascular Coagulopathy (DIC) is the most common coagulopathy in patients with prostate cancer. Though rare, it could be fatal without treatment. Literature suggests that there is significant activation of fibrinolytic pathway. Pathophysiology of DIC in patients with prostate cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Keisuke Shirai, Uzair B. Chaudhary
Format: Article
Language:English
Published: Wiley 2007-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2007.143
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558792874655744
author Keisuke Shirai
Uzair B. Chaudhary
author_facet Keisuke Shirai
Uzair B. Chaudhary
author_sort Keisuke Shirai
collection DOAJ
description Disseminated Intravascular Coagulopathy (DIC) is the most common coagulopathy in patients with prostate cancer. Though rare, it could be fatal without treatment. Literature suggests that there is significant activation of fibrinolytic pathway. Pathophysiology of DIC in patients with prostate cancer is not completely understood. We present here a case of chronic DIC in a patient with metastatic androgen independent prostate cancer. His DIC was managed successfully with a combination of aminocaproic acid and low weight molecular heparin. The use of low molecular weight heparin may make management of chronic DIC in prostate cancer more feasible in an out patient setting.
format Article
id doaj-art-48d281b587404c869a2b061b5e017276
institution Kabale University
issn 1537-744X
language English
publishDate 2007-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-48d281b587404c869a2b061b5e0172762025-02-03T01:31:35ZengWileyThe Scientific World Journal1537-744X2007-01-01775375510.1100/tsw.2007.143Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case ReportKeisuke Shirai0Uzair B. Chaudhary1Department of Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USADepartment of Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USADisseminated Intravascular Coagulopathy (DIC) is the most common coagulopathy in patients with prostate cancer. Though rare, it could be fatal without treatment. Literature suggests that there is significant activation of fibrinolytic pathway. Pathophysiology of DIC in patients with prostate cancer is not completely understood. We present here a case of chronic DIC in a patient with metastatic androgen independent prostate cancer. His DIC was managed successfully with a combination of aminocaproic acid and low weight molecular heparin. The use of low molecular weight heparin may make management of chronic DIC in prostate cancer more feasible in an out patient setting.http://dx.doi.org/10.1100/tsw.2007.143
spellingShingle Keisuke Shirai
Uzair B. Chaudhary
Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
The Scientific World Journal
title Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
title_full Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
title_fullStr Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
title_full_unstemmed Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
title_short Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
title_sort use of low molecular weight heparin and aminocaproic acid in chronic dic associated with prostate cancer a case report
url http://dx.doi.org/10.1100/tsw.2007.143
work_keys_str_mv AT keisukeshirai useoflowmolecularweightheparinandaminocaproicacidinchronicdicassociatedwithprostatecanceracasereport
AT uzairbchaudhary useoflowmolecularweightheparinandaminocaproicacidinchronicdicassociatedwithprostatecanceracasereport